Once-daily Compared With Twice-daily Enoxaparin Maintenance Therapy Appears Safe and Efficacious in Pediatric Venous Thromboembolism.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of pediatric hematology/oncology"
DOI: 10.1097/mph.0000000000002601
Abstract: INTRODUCTION Once-daily enoxaparin (ODE), considered standard of care for venous thromboembolism (VTE) treatment in adults, has been infrequently assessed in children. To contribute available data to a limited field, we reviewed our center's experience with… read more here.
Keywords: maintenance therapy; vte; ode; daily enoxaparin ... See more keywords
The Impact of Once- versus Twice-Daily Enoxaparin Prophylaxis on Risk for Venous Thromboembolism and Clinically Relevant Bleeding
Sign Up to like & getrecommendations! Published in 2018 at "Plastic and Reconstructive Surgery"
DOI: 10.1097/prs.0000000000004517
Abstract: Background: Venous thromboembolism is a life- or limb-threatening complication that occurs in plastic surgery patients. At present, the optimal dose of enoxaparin that balances the risk of venous thromboembolism and the risk of medication-related adverse… read more here.
Keywords: daily enoxaparin; twice daily; venous thromboembolism; clinically relevant ... See more keywords